CEO Executive AssistantScientific advisory boards are among the most valuable strategic assets a pharmaceutical company can cultivate. A well-constituted SAB connects the CEO and scientific leadership to world-class expertise in disease biology, clinical development, regulatory science, and translational medicine. The personal assistant who manages the CEO’s SAB relationships provides value that extends well beyond meeting logistics, functioning as a coordinator of one of the company’s most important external scientific networks.
What Scientific Advisory Boards Do for Pharma CEOs
A pharmaceutical company’s scientific advisory board serves several distinct functions. It provides external scientific validation of the company’s research programs, which has value with investors, partners, and regulators who look to SAB composition as a signal of scientific credibility. It provides access to leading researchers who can identify emerging science relevant to the company’s programs. It offers a forum for candid scientific critique that helps the internal team identify weaknesses in their approaches before they become expensive clinical failures.
For the CEO specifically, the SAB represents access to perspectives that are difficult to obtain through internal channels alone. Academic KOLs, former FDA reviewers, and disease-area thought leaders bring perspectives shaped by decades of engagement with the science and clinical practice that no internal team can fully replicate.
Managing these relationships is not simply a matter of scheduling an annual meeting. The most effective SAB relationships are maintained through regular informal engagement, careful attention to each advisor’s interests and concerns, and thoughtful cultivation of the relationship over time.
The PA’s Role in SAB Management
The personal assistant supports SAB management in several distinct ways, depending on the company’s size and the formality of its SAB structure.
Meeting logistics: SAB meetings, whether in-person or virtual, require substantial logistical support. The PA coordinates scheduling across multiple distinguished academics and clinicians, many of whom have demanding travel and clinical schedules. In-person SAB meetings often include dinner the evening before the formal session, which the PA plans and manages as part of the overall event.
Member communications: Between formal meetings, the CEO may want to share clinical updates, seek individual advisors’ opinions on specific questions, or simply maintain relationships with key SAB members. The PA manages the correspondence involved in these ongoing communications, drafts briefing notes on advisor backgrounds before CEO interactions, and tracks the cadence of CEO-advisor engagement.
Contract and compliance management: SAB relationships typically involve consulting agreements, confidentiality agreements, and in some cases equity grants. The PA coordinates with legal and finance to ensure that these agreements are executed and maintained, that compensation is processed on schedule, and that any conflicts of interest disclosures required by academic institutions are managed properly.
New member recruitment support: When the company seeks to add new SAB members, the PA supports the recruitment process by coordinating introductory calls, managing the disclosure and agreement execution process, and ensuring that new members receive appropriate orientation materials.
Preparing the CEO for SAB Interactions
Every SAB meeting and every individual advisor interaction is an opportunity for the CEO to strengthen a scientific relationship that may prove valuable for years. The PA prepares the CEO for these interactions by compiling briefing materials that include each advisor’s current research interests, their most recent publications relevant to the company’s programs, any news from their institution or department, and context from previous conversations with the CEO.
This preparation enables the CEO to have substantive, personalized conversations rather than generic interactions. A CEO who can comment knowledgeably on an advisor’s recently published paper or ask a thoughtful follow-up question about a concern raised at the previous meeting builds much stronger relationships than one who approaches each interaction without specific context.
SAB Meeting Preparation
SAB meetings typically follow a structured format that includes company program updates, scientific presentations by internal or external researchers, and advisory board discussions on specific strategic questions. Preparing for these meetings requires coordinating with multiple internal teams and ensuring that the meeting agenda, format, and content are designed to make the best use of the SAB’s time.
The PA coordinates:
Agenda development: Working with the CSO, VP of R&D, and the CEO to build an agenda that addresses the most important questions the SAB can help answer, while maintaining time for broader scientific dialogue.
Material preparation: Collecting and formatting scientific presentations, program updates, and background materials for distribution to SAB members in advance of the meeting.
Logistical arrangements: For in-person meetings, managing venue selection, catering, AV equipment, and transportation logistics. For virtual meetings, ensuring that the technology platform supports clear presentation of scientific data.
Follow-up documentation: After the meeting, coordinating the preparation of meeting minutes that capture the SAB’s key recommendations and observations, and tracking follow-up actions committed to by internal teams.
Managing Individual Advisor Relationships
Not all SAB relationships are equally active or formal. Some advisors engage primarily through annual meetings, while others are in regular contact with the CEO or scientific leadership on specific questions. The PA maintains a relationship map that tracks the cadence and nature of engagement with each advisor, helping the CEO and CSO manage the portfolio of SAB relationships strategically.
For advisors who are particularly close to the company’s programs, the PA may manage a more intensive engagement, including scheduling regular calls, coordinating document reviews, and managing the advisor’s engagement with internal teams working on relevant programs.
Compliance and Conflict Management
Scientific advisory board members are often active in academic research, consult with multiple pharmaceutical companies, and may have investment portfolios that create potential conflicts. The PA supports the compliance process for managing these conflicts, working with the legal and compliance teams to ensure that:
- Annual conflict of interest disclosures are obtained from each SAB member
- Any new conflicts arising during the year are identified and managed
- Compensation to SAB members is appropriately disclosed in company SEC filings
- Sunshine Act reporting requirements (where applicable) are met for SAB member payments
For more on the PA’s full range of responsibilities supporting pharmaceutical executives, see pharma PA duties. The pharma CEO assistant overview provides additional context on executive support in the pharmaceutical industry.
Conclusion
Scientific advisory board management is one of the more intellectually demanding components of a pharmaceutical CEO’s PA role. The PA who manages this function effectively contributes to the company’s scientific credibility, supports the CEO’s most important scientific relationships, and helps ensure that the SAB’s expertise is effectively mobilized in service of the company’s development programs. In an industry where scientific advice from the right experts can change the direction of clinical programs worth hundreds of millions of dollars, this is work that deserves serious attention and investment.
Related Reading
For further context, explore Personal Assistant for 3PL CEO Third Party Logistics: Operational Support for a High-Volume Industry and Personal Assistant for Abrasive Manufacturer CEO.